Back
ESC Premium Access

Impact of polypharmacological strategy on mortality and morbidity in predominantly older HF population across different HF phenotype.

Session: Poster session 7 - Heart failure / Left ventricular dysfunction
Topic: Prognosis
Speaker: Doctor A. Iorio (Trieste, IT)
Event: ESC Congress 2016

Congress Presentation

Add to my library

Like

About the speaker

Doctor Annamaria Iorio

United Hospitals of Trieste University Hospital, Trieste (Italy)
0 follower

49 more presentations in this session

Survival in HFpEF vs HFrEF patients after beta-blocker titration: new insights from the CIBIS-ELD trial

Speaker: Professor H. Duengen (Berlin, DE)

Access
Abstract
Like
Thumbnail

Dual V1a/V2 versus selective V2 vasopressin receptor blockade in a preclinical heart failure model: does it matter?

Speaker: Doctor T. Mondritzki (Wuppertal, DE)

Access
Abstract
Slides
Like
Thumbnail

The use of Guideline recommended betablocker therapy in primary prevention ICD patients. Insight from Danish nationwide registries

Speaker: Doctor A. Huth Ruwald (Copenhagen, DK)

Access
Abstract
Slides
Like
Thumbnail

The effect of angiotensin II type 2 receptor agonist treatment on doxorubicin induced heart failure

Speaker: Associate Professor N. Ermis (Malatya, TR)

Access
Abstract
Slides
Like
Thumbnail

Triiodo-L-thyronine promotes the therapeutic efficacy for myocardial infarction of bone marrow mesenchymal stem cells

Speaker: Professor S. Nie (Beijing, CN)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster session 7 - Heart failure / Left ventricular dysfunction

Speakers: Doctor A. Iorio, Professor H. Duengen, Doctor T. Mondritzki, Doctor A. Huth Ruwald, Associate Professor N. Ermis...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources